IOVA Iovance Biotherapeutics Net earnings per share growth this year

IOVA (Iovance Biotherapeutics) - company brandmark

The expansion of production capacities and the modernization of lines allow Iovance Biotherapeutics (IOVA) to scale the production of Amtagvi, creating a foundation for stable cash flow. The annual change in EPS reflects profit dynamics, with the current figure standing at 64.90. Business development relies on the medical necessity of cancer therapy, rendering the company independent of macroeconomic cycles and global GDP.

Iovance Biotherapeutics, Inc. (IOVA): Net earnings per share growth this year from 07/04/2022 to 11/16/2026

Analytical breakdowns and data insights for company Iovance Corp (IOVA)

- current quotes and average value forecast:
Summary company analysis:IOVA (Iovance Biotherapeutics)
Brand item of Iovance

This indicator measures the year-over-year dynamics of net income per share, allowing for an assessment of the real efficiency of business scaling without market noise. Analyzing the growth of earnings per share compared to the previous year is critically important for Iovance Biotherapeutics (IOVA), as it reflects the impact of geopolitical risks and patent barriers on the actual monetization of biotechnological developments.

Key competitors

IBRX - Expected net earnings per share growth this year|Earnings per share growth in current year immunocore.com|Net earnings per share growth this year januxrx.com (JANX)|Earnings per share growth in current year Arcus Biosciences Inc (RCUS)|Net earnings per share growth this year Zymeworks Corp ZYME|Tango Therapeutics Inc - Net earnings per share growth this year|Earnings growth in current year Immatics Biotechnologies IMTX|XNCR - Earnings per share growth in current year|CMPX (compasstherapeutics.com) - Earnings per share growth this year|Replimune Inc. (REPL) - Earnings per share growth in current year|Earnings per share growth rate in current year Lyell Immunopharma Inc (LYEL)|Net earnings per share growth this year IPHA|PYXS - Net earnings per share change in current year|Net earnings per share growth this year CGEN (Compugen Ltd.)|Net earnings per one share growth for the current year IOBT|Earnings growth in current year STRO (Sutro Biopharma)|Earnings per share increase in current year INKT|Werewolf - Earnings growth in current year|Earnings per share growth rate in current year Immix Biopharma|ALX Oncology (ALXO) - Earnings per share growth in current year|cuebiopharma.com (CUE) - Earnings growth in current year|PDSB (PDS Biotechnology Corp) - Earnings growth in current year|Earnings growth in current year sonnetbio.com|Earnings per share growth in current year MAIA Biotechnology, Inc. (MAIA)|LIMN: Earnings per share trend in current year|LAVA Therapeutics - Net earnings per share growth this year|nextcure.com (NXTC) - Earnings per share growth rate in current year|LPTX - Earnings per share growth in current year|Expected net earnings per share growth this year Intensity Therapeutics, Inc. INTS|SNSE: Earnings growth in current year|Synthetic Biologics - Earnings per share increase in current year|GRTS (Gritstone bio) - Earnings growth in current year|KA (Kineta, Inc.) - Net earnings per one share growth for the current year|Earnings growth in current year NEXI|Turnstone Biologics Corp - Earnings per share growth this year|Earnings growth in current year VCNX (Vaccinex Inc)|Harpoon Therapeutics Corp (HARP) - Earnings per share growth rate in current year